0

Gadoversetamide Related Compound A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATCS31041718
Molecular Weight604.67
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size200MG
1

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of OptiMARK (Gadoversetamide Injection) Compared With Magnevist (Gadopentetate Dimeglumine) in Patients With Liver Pathology: Results of a Phase III Clinical Trial

D L Rubin, T S Desser, R Semelka, J Brown, H V Nghiem, W R Stevens, D Bluemke, R Nelson, P Fultz, P Reimer, V Ho, R M Kristy, J A Pierro

J Magn Reson Imaging. 1999 Feb;9(2):240-50.

PMID: 10077020

1

Pharmacokinetics and Safety of the MRI Contrast Agent Gadoversetamide Injection (OptiMARK) in Healthy Pediatric Subjects

James F Baker, Linda C Kratz, Gary R Stevens, James H Wible Jr

Invest Radiol. 2004 Jun;39(6):334-9.

PMID: 15167099

1

The Safety and Efficacy of Neuroimaging With Gadoversetamide Injection in Pediatric Patients

Lisa H Lowe, Gregory L Kearns, James H Wible Jr

Curr Med Res Opin. 2006 Dec;22(12):2515-24.

PMID: 17166334

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode